While GM-CSF inhibitors are under development, showing no success in psoriasis but varying success in other inflammatory conditions such as rheumatoid arthritis, this mechanism of action has not been evaluated in hidradenitis suppurativa, warranting further investigation [37,38]. Here, CSF2 is linked to rheumatoid arthritis.